EPISODE · Nov 10, 2022 · 11 MIN
Depression And Alzheimer's Treatments At A Crossroads
from Short Wave
Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem. As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy
NOW PLAYING
Depression And Alzheimer's Treatments At A Crossroads
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·12m
Mar 26, 2026 ·13m
Feb 5, 2026 ·11m
Jan 27, 2026 ·3m
Dec 31, 2025 ·13m